AccuStem Sciences, Inc. (ACUT)
OTCMKTS
· Delayed Price · Currency is USD
2.100
-0.110 (-4.98%)
At close: Aug 12, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $34.39 million as of August 14, 2025. Its market cap has increased by 441.30% in one year.
Market Cap
34.39M
Enterprise Value
34.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.10
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has increased from 20.42M to 34.39M, an increase of 68.44%. That is a compound annual growth rate of 16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 33.75M | 563.98% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 625.65M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 367.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |